Network Bio
Network Bio16About
What does Network Bio do?
Network Bio is a biotechnology company building disease-specific AI models from human biological data to support the personalized practice of medicine. They utilize artificial intelligence and a research network of leading U.S. academic biobanks to create the world's largest patient tissue training dataset, linked to blood samples and clinical outcomes. Their platform centralizes research-grade data assets, serving as a neutral broker between healthcare institutions and industry partners to enab…
Is Network Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Network Bio is 20 out of 100, based on site security posture and privacy practices.
What is Network Bio's revenue?
StartupHub estimates Network Bio's annual revenue at $2.3M (range $1.5M to $8.2M, 67% confidence), based on comparable companies in the sector.
What is Network Bio's valuation?
StartupHub estimates Network Bio's effective valuation at $911.4M (range $638.0M to $1.2B, 42% confidence), based on comparable companies in the sector.
How much funding has Network Bio raised?
Network Bio has raised a total of $100M in funding. The most recent round on record is Seed.
Where is Network Bio headquartered?
Network Bio is headquartered in Palo Alto, United States.
When was Network Bio founded?
Network Bio was founded in 2023.
What industry does Network Bio operate in?
Network Bio operates in Biotechnology, Artificial Intelligence, Drug Discovery, Healthcare, Biotech, AI Drug Discovery.
How many employees does Network Bio have?
Network Bio has approximately 24 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.